Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15570000 | 0.90 | SYK (1.00) | SYK | |
| SCHEMBL15569920 | 0.85 | SYK (0.74) | SYK | |
| SCHEMBL15569438 | 0.82 | SYK (1.00) | SYK | |
| SCHEMBL15569915 | 0.74 | SYK (1.00) | SYK | |
| SCHEMBL15569604 | 0.73 | SYK (1.00) | SYK | |
| SCHEMBL15569702 | 0.71 | SYK (0.56) | SYK | |
| SCHEMBL15569766 | 0.71 | SYK (0.54) | SYK | |
| SCHEMBL20125539 | 0.69 | SYK (0.73) | SYK | |
| SCHEMBL15569700 | 0.67 | SYK (0.69) | SYK | |
| SCHEMBL15569376 | 0.66 | SYK (1.00) | SYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9334278-B2 | Pyrrolo[2,3-B]pyrazines as SYK inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2016-05-10 | — | — | US | claimed |
| US-20150218170-A1 | PYRROLO[2,3-B]PYRAZINES AS SYK INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2015-08-06 | — | — | US | claimed |
| EP-2888262-A1 | PYRROLO[2,3-B]PYRAZINES AS SYK INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2015-07-01 | — | — | EP | claimed |
| WO-2014029732-A1 | PYRROLO[2,3-B]PYRAZINES AS SYK INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2014-02-27 | — | — | WO | claimed |
| EP-2888262-B1 | PYRROLO[2,3-B]PYRAZINES AS SYK INHIBITORS | HOFFMANN LA ROCHE (CH) | 2018-12-19 | — | — | EP | disclosed |
| US-9334278-B2 | Pyrrolo[2,3-B]pyrazines as SYK inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-9334278-B2 | Pyrrolo[2,3-B]pyrazines as SYK inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-9334278-B2 | Pyrrolo[2,3-B]pyrazines as SYK inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-20150218170-A1 | PYRROLO[2,3-B]PYRAZINES AS SYK INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2015-08-06 | — | — | US | disclosed |
| US-20150218170-A1 | PYRROLO[2,3-B]PYRAZINES AS SYK INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2015-08-06 | — | — | US | disclosed |
| US-20150218170-A1 | PYRROLO[2,3-B]PYRAZINES AS SYK INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2015-08-06 | — | — | US | disclosed |
| EP-2888262-A1 | PYRROLO[2,3-B]PYRAZINES AS SYK INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2015-07-01 | — | — | EP | disclosed |
| WO-2014029732-A1 | PYRROLO[2,3-B]PYRAZINES AS SYK INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2014-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150218170-A1 | PYRROLO[2,3-B]PYRAZINES AS SYK INHIBITORS | SYK, ZAP70, BTK | SYK 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.